Carregant...
Everolimus (RAD001) in the Treatment of Advanced Renal Cell Carcinoma: A Review
Historically, there have been few treatment options for patients with advanced renal cell carcinoma (RCC) besides immunotherapy with interleukin-2 and interferon (IFN)-α. Targeted therapies have improved clinical outcomes over the past several years. These include the vascular endothelial growth fac...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AlphaMed Press
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3227953/ https://ncbi.nlm.nih.gov/pubmed/20215359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0141 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|